NGS Leads as Precision Medicine, Oncology and NIPT Adoption Accelerates, While Long-Read Sequencing, AI Bioinformatics and Pharma Partnerships Unlock OpportunitiesDublin, Oct. 09, 2026 (GLOBE NEWSWIRE ...
Next-generation sequencing, oncology and rare-disease diagnostics, and genomics investment drive growth, with North America leading the market.Dublin, Sept. 29, 2026 (GLOBE NEWSWIRE) -- "DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results